Research highlightEngineered nucleus-free mesenchymal stem cells (MSCs) for the targeted delivery of therapeutics to disease site
Under a Creative Commons license
open access
Cited by (0)
Peer review under responsibility of Chongqing Medical University.
© 2022 The Authors. Publishing services by Elsevier B.V. on behalf of KeAi Communications Co., Ltd.